Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B6372 OBAASummary: phospholipase A2 inhibitor -
B6500 Cilostamide1 CitationSummary: type III phosphodiesterase (PDE3) inhibitor -
B6617 SiguazodanSummary: PDE3 inhibitor -
B6662 EHNA hydrochlorideSummary: cGMP-stimulated phosphodiesterase (PDE2) and adenosine deaminase inhibitor -
B6681 CiglitazoneSummary: PPARγ agonist -
B6691 BADGESummary: PPARγ antagonist -
B6748 AACOCF32 CitationSummary: Inhibitor of cPLA2/anandamide hydrolysis/FAAH -
A4015 DisulfiramTarget: Aldehyde DehydrogenasesSummary: Dopamine β-hydroxylase inhibitor -
A4054 17-AAG (KOS953)3 CitationSummary: Hsp90 inhibitor -
A4056 AT13387Target: HSP90Summary: Hsp90 inhibitor

